Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-25

Clinical Trial Update: Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis Regimen [Phase 2]

View source ↗

Summary

Two vaccines were compared in a Phase 2 pre-exposure rabies prophylaxis trial and the study has completed. The trial was sponsored by Sanofi Pasteur.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Diploid Cell Vaccine (Rabies vaccine, human diploid cell)
  • Purified Vero Rabies Vaccine Serum Free (Purified Vero Rabies Vaccine Serum Free)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Rabies | Phase 2 | Status: COMPLETED